Health AI in the 2nd Week of April

Penguin Ai (US): launched Gwen, a build-your-own AI platform enabling health systems to deploy digital workers through simple prompts. With over 100 pre-built agents, it targets rapid automation of administrative workflows. [Link]

Counsel Health (US): expanded its AI-enabled care platform into chronic condition management, including hypertension, obesity, and cholesterol care. [Link]

Ambience Healthcare (US): released Chart Chat for Nursing, a conversational tool that provides citation-backed answers from patient charts, notes, orders, and labs inside the EHR. [Link]

BD (US): introduced an AI-enabled medication dispensing system in Europe, combining automated hardware with AI-driven analytics to improve inventory visibility and medication management. [Link]

Clinical AI (US): highlighted MAIA Prescreening for automating trial prescreening from patient notes. A case study reported >80% higher enrollment and accuracy above 95%. [Link]

Abridge (US): unveiled a context-aware clinical decision support feature that uses the patient conversation to surface cited, evidence-based insights inside workflow. [Link]

Smarter Technologies (US): launched an AI-powered inpatient utilization management platform. The system connects clinical and financial workflows to support faster decisions and reduce avoidable claim denials. [Link]

IKS Health (US): launched an autonomous coding solution with claimed accuracy of up to 95%, designed to reduce denials and support audit-ready claims. The system is integrated with Epic and available through the Epic Connection Hub. [Link]

Reveleer (US): launched a clinical data repository to unify records across payer workflows. The platform aims to reduce data retrieval effort by 30–60% through reusable, AI-enriched clinical records. [Link]

Aide Health (UK): rolled out daily AI support for 55,000 patients to help manage chronic conditions. The initiative aims to ease pressure on services through symptom monitoring, medication support, and earlier intervention. [Link]

XRP Healthcare (Global): announced XRPHAI, a utility token tied to verified health and wellness activity in its AI healthcare platform. [Link]

HHS (US): reorganized its technology leadership, moving the Chief AI Officer back under OCIO. The shift centralizes enterprise technology functions to support a more unified, AI-enabled health system. [Link]

UnitedHealth Group (US): Expanding AI across claims, billing, and care operations at scale. The shift raises concerns about transparency as algorithms increasingly influence patient-facing decisions. [Link]

AHA (US): outlined four policy priorities to accelerate AI adoption, including reducing regulatory barriers and strengthening oversight of AI developers. [Link]

Mental Health AI Use (Canada): a national commentary highlighted rising use of AI for mental health support, with around 10% of Canadians reporting use. It also raised concerns around bias, stigma, and potential harm from chatbot-based support. [Link]

UK Jurisdiction Taskforce (UK): confirmed that AI holds no legal personality under English law, with a forthcoming legal statement expected to clarify how liability for AI-related harm will be assigned. [Link]

AI Scribes and Clinician Workload: a multisite study of 8,581 clinicians found AI scribe adoption reduced documentation time by 16 minutes per 8 patient hours and was associated with a small increase in weekly visit volume. [Link]

Vocal Biomarkers (US/Germany): a pilot study found AI-based voice analysis distinguished heart failure admission and discharge phases with strong performance (AUC 0.90). The approach offers a non-invasive method for monitoring changes during hospitalization. [Link]

Oral Cancer Diagnostics (Global): an AI model combining breath analysis and metagenomics achieved strong performance (ROC-AUC 0.92) in detecting oral cancer in an external validation cohort. The approach offers a non-invasive screening method. [Link]

Thoracic Radiotherapy: a multicenter trial found AI-assisted delineation reduced contouring time by 81.6% while improving accuracy compared to manual methods. [Link]

LLM vs. RCT Benchmarks: a study found ChatGPT and Gemini showed the highest agreement with published clinical trial conclusions, though results may be influenced by prior training on those trials. [Link]

Mount Sinai & OpenEvidence (US): collaborated to embed evidence-based AI directly into Epic. The rollout is OpenEvidence’s first enterprise-scale deployment to include nurses and pharmacists alongside physicians. [Link]

Avo & EBSCO Clinical Decisions (US): integrated DynaMed’s knowledge base into the Avo platform, bringing evidence-based guidance into EHR workflows. [Link]

PathAI & MedStar Health (US): partnered to deploy a digital pathology platform across MedStar’s network, supporting 40+ pathologists. The collaboration also opens the door to joint research and future real-world data generation. [Link]

Ambience Healthcare & Cleveland Clinic (US): launched a pilot of Chart Chat for inpatient nursing, an EHR-integrated conversational AI tool to help nurses quickly interpret patient charts. [Link]

OpenEvidence & Tandem (US): partnered to link evidence-based clinical decision support with prescribing and prior authorisation workflows, aiming to reduce treatment delays. [Link]

eClinicalWorks × CLEAR × b.well (US): executed a real-world production transaction for CMS’s “Kill the Clipboard” initiative, enabling patient data import via SMART Health QR code. [Link]

CHAH AI Care & Quoted Tech (Canada): partnered to deploy AI-powered home healthcare monitoring hubs in Ontario, bringing continuous monitoring and earlier risk detection into patients’ homes. [Link]

WHOOP (US): raised $575M at a $10.1B valuation to expand its wearable health platform and invest in more medical-grade products. [Link]

Jimini Health (US): secured $17M in seed funding to expand its clinician-supervised AI platform for behavioural health. Its core product, Sage, is designed to support patients between sessions while keeping licensed providers in control. [Link]

Insight Health (US): raised $11M in Series A funding to scale its AI clinical agent platform. Its voice-first agents are built to reduce administrative burden across patient intake, triage, and clinical documentation. [Link]

Avo (US): secured $10M in Series A funding to expand its clinical AI platform, designed to bring trusted knowledge into EHR workflows and support more informed clinical decisions. [Link]

Mediwhale (South Korea): secured $13M in Series C funding to advance its retina-based cardiovascular risk AI platform. The funding will support US clinical trials, regulatory approvals, and broader global expansion. [Link]

Anthropic (US): acquired stealth biotech startup Coefficient Bio in a reported $400M all-stock deal, deepening its push into healthcare and life sciences. [Link]